The cost of antibiotic therapy and antibiotic resistance for complicated intra-abdominal infections (cIAIs) and complicated urinary tract infections (cUTIs) in Italy

The cost of antibiotic therapy and antibiotic resistance for complicated intra-abdominal infections (cIAIs) and complicated urinary tract infections (cUTIs) in Italy

The cost of antibiotic therapy and antibiotic resistance for complicated intra-abdominal infections (cIAIs) and complicated urinary tract infections (cUTIs) in ItalyObjectiveTo assess costs associated with the treatment of community-acquired cIAIs and cUTIs, from the Italian National Health Service...

Full description

Bibliographic Details
Main Authors:	Paola Saturnino, Maria Pia Mannelli, Roberto Ravasio
Format:	Article
Language:	English
Published:	AboutScience Srl 2017-11-01
Series:	Global & Regional Health Technology Assessment
Online Access:	http://www.grhta.com/Attach/BEC8CC72-4735-45E8-927C-4D3F1E31B072/6373750D-F256-4CB7-86FC-727B282F6BA2

Similar Items

Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
by: Thitima Kongnakorn, et al.
Published: (2019-12-01)

An Evidence-Based Multidisciplinary Approach Focused at Creating Algorithms for Targeted Therapy of BSIs, cUTIs, and cIAIs Caused by Enterobacterales in Critically Ill Adult Patients
by: Gatti M, et al.
Published: (2021-06-01)

Efficacy and safety of ceftazidime-avibactam in the treatment of complicated intra-abdominal infections (CIAIs) and complicated urinary tract infections (CUTIs): A meta-analysis of randomized controlled trials
by: Yue Zhang, et al.

Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline
by: Wanda C Reygaert
Published: (2010-09-01)

The role of the intra-abdominal view in complicated intra-abdominal infections
by: Matti Tolonen, et al.
Published: (2019-03-01)

Clinical and economic consequences of failure of initial antibiotic therapy for patients with community-onset complicated intra-abdominal infections.
by: Yong Pil Chong, et al.
Published: (2015-01-01)

Pylephlebitis: An Uncommon Complication of Intra-Abdominal Infection
by: Salim R Surani, et al.
Published: (2011-05-01)

Effective Antibiotic Therapy of Complicated Urinary Tract Infections
by: O.D. Nikitin
Published: (2015-10-01)

Doripenem in hospital infections: a focus on nosocomial pneumonia, complicated intra-abdominal infections, and complicated urinary tract infections
by: Tze Shien Lo, et al.
Published: (2009-06-01)

The impact of initial antibiotic treatment failure: real-world insights in patients with complicated, health care-associated intra-abdominal infection
by: Peeters P, et al.
Published: (2019-01-01)

Antibiotic Resistance in Children with Recurrent or Complicated Urinary Tract Infection
by: Nidal S Younish, et al.
Published: (2009-01-01)

Predicting mortality in surgery for complicated intra-abdominal infections
by: João Pedro Mestre da Costa
Published: (2019)

Pylephlebitis: a rare complication of an intra-abdominal infection
by: Katherine Wong, et al.
Published: (2013-07-01)

Intra-abdominal infection (IAI) following cesarean section: a retrospective study in a tertiary referral hospital in Egypt
by: Ahmed R. Abdelraheim, et al.
Published: (2019-07-01)

Analysis of patients with diabetes and complicated intra-abdominal infection or complicated urinary tract infection in phase 3 trials of ceftolozane/tazobactam
by: Myra W. Popejoy, et al.
Published: (2017-05-01)

Antibiotic therapy and infection complications in paediatric burn injuries
by: Jakub Noskiewicz, et al.
Published: (2019-05-01)

Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections
by: Giancola SE, et al.
Published: (2016-05-01)

EMPIRICAL THERAPY OF COMPLICATED URINARY TRACT INFECTIONS IN CONDITIONS OF NOSOCOMIAL INFECTION ANTIBIOTIC RESISTANCE GROWTH
by: Sarychev L. P., et al.
Published: (2018-11-01)

Recurrent Urinary Tract Infections: Unraveling the Complicated Environment of Uncomplicated rUTIs
by: Jonathan Josephs-Spaulding, et al.
Published: (2021-07-01)

PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS
by: Yu. M. Gomon, et al.
Published: (2017-12-01)

Complicated Intra-Abdominal Infections Observational European study (CIAO Study)
by: Sartelli Massimo, et al.
Published: (2011-12-01)

Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
by: Goodlet KJ, et al.
Published: (2016-12-01)

Antibiotic Prescribing in Primary Care for Urinary Tract Infections (UTIs) in Pregnancy: An Audit Study
by: Flavia Ghouri, et al.
Published: (2020-09-01)

Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment
by: João António da Silva Nunes
Published: (2019)

Intra-abdominal infections: the role of different classifications on the selection of the best antibiotic treatment
by: João Silva-Nunes, et al.
Published: (2019-11-01)

Intra-abdominal Complications of Sarcoidosis
by: Kristin Loening MacArthur, et al.
Published: (2010-07-01)

Ceftazidime/avibactam: a novel cephalosporin/nonbeta-lactam beta-lactamase inhibitor for the treatment of complicated urinary tract infections and complicated intra-abdominal infections
by: Hidalgo JA, et al.
Published: (2016-07-01)

Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
by: Skalweit MJ
Published: (2015-06-01)

Complicated intra-abdominal infections in Europe: a comprehensive review of the CIAO study
by: Sartelli Massimo, et al.
Published: (2012-11-01)

Treatment of complicated intra-abdominal infections in the era of multi-drug resistant Bacteria
by: Herzog T, et al.
Published: (2010-11-01)

Culture-and nonculture-based antibiotics for complicated soft tissue infections are comparable
by: Ronald Irwanto, et al.
Published: (2013-04-01)

Culture-and nonculture-based antibiotics for complicated soft tissue infections are comparable
by: Ronald Irwanto, et al.
Published: (2015-12-01)

Ceftolozane/tazobactam for the treatment of complicated intra-abdominal and urinary tract infections: current perspectives and place in therapy
by: Escolà-Vergé L, et al.
Published: (2019-07-01)

THE HIGH ELEVATION OF C-REACTIVE PROTEIN LEVELS AT ADMISSION REPRESENTS AN EARLY MORTALITY PREDICTOR IN PATIENTS WITH COMPLICATED INTRA-ABDOMINAL INFECTIONS
by: E. Dimitrov, et al.
Published: (2020-12-01)

Examining the inter-relationships between antibiotic prescribing, complications and resistance in acute respiratory tract infections
by: Cannings-John, Rebecca
Published: (2013)

Antimicrobial Resistance of Gram-negative Microorganisms Causing Complicated Intra-abdominal Infections in Russia
by: Kozlov R.S., et al.
Published: (2015-08-01)

Defining the Scope of Antimicrobial Stewardship Interventions’ on the Prescription Quality of Antibiotics for Surgical Intra-Abdominal Infections
by: Güzin Surat, et al.
Published: (2021-01-01)

Prevalence and antibiotic susceptibility of Uropathogens from cases of urinary tract infections (UTI) in Shashemene referral hospital, Ethiopia
by: Wubalem Desta Seifu, et al.
Published: (2018-01-01)

Complicated nosocomial UTI caused by nonfermenters
by: S K Meharwal, et al.
Published: (2002-01-01)

Complicated intra-abdominal infections in Europe: preliminary data from the first three months of the CIAO Study
by: Sartelli Massimo, et al.
Published: (2012-05-01)

Cannot write session to /tmp/vufind_sessions/sess_fq40marf6nrevlhn5gl8p1pg87